Cefuroxime axetil (oral): Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cefuroxime axetil}} | |||
{{CMG}};{{AE}}{{AK}} | |||
==Overview== | |||
Cefuroxime axetil is a second generation oral cephalosporin antibiotic. It was discovered by Glaxo now GlaxoSmithKline and introduced in 1987 asZinnat.[1] It was approved by FDA on Dec 28, 1987.[2] It is available by GSK as Ceftin in US | |||
It is an acetoxyethyl ester prodrug of cefuroxime which is effective orally.The activity depends on in vivo hydrolysis and release of cefuroxime. | |||
==Category== | |||
Cephalosporins, second generation. | |||
==US Brand Names== | |||
CEFTIN<sup>®</sup> | |||
==FDA Package Insert== | |||
'''[[Cefuroxime axetil description|Description]]''' | |||
'''| [[Cefuroxime axetil clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Cefuroxime axetil microbiology|Microbiology]]''' | |||
'''| [[Cefuroxime axetil indications and usage|Indications and Usage]]''' | |||
'''| [[Cefuroxime axetil contraindications|Contraindications]]''' | |||
'''| [[Cefuroxime axetil warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Cefuroxime axetil adverse reactions|Adverse Reactions]]''' | |||
'''| [[Cefuroxime axetil overdosage|Overdosage]]''' | |||
'''| [[Cefuroxime axetil dosage and administration|Dosage and Administration]]''' | |||
'''| [[Cefuroxime axetil compatibility and stability|Compatibility and Stability]]''' | |||
'''| [[Cefuroxime axetil how supplied|How Supplied]]''' | |||
'''| [[Cefuroxime axetil labels and packages|Labels and Packages]]'' | |||
==References== | |||
{{Reflist|2}} | |||
http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050605s042lbl.pdf | |||
[[Category:Antibiotics]] | |||
[[Category:Wikinfect]] | |||
Revision as of 03:44, 6 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Overview
Cefuroxime axetil is a second generation oral cephalosporin antibiotic. It was discovered by Glaxo now GlaxoSmithKline and introduced in 1987 asZinnat.[1] It was approved by FDA on Dec 28, 1987.[2] It is available by GSK as Ceftin in US
It is an acetoxyethyl ester prodrug of cefuroxime which is effective orally.The activity depends on in vivo hydrolysis and release of cefuroxime.
Category
Cephalosporins, second generation.
US Brand Names
CEFTIN®
FDA Package Insert
References
http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050605s042lbl.pdf